user

Molecular mechanism(s) of resistance to vandetanib in medullary thyroid carcinoma.

被引：0
|
作者：
Glassberg, Brittany
Khan, Sophia
Pemov, Alex
Hawley, Robert
Widemann, Brigitte C.
Khan, Javed
Glod, John
机构：
[1] NIH, Bldg 10, Bethesda, MD 20892 USA
[2] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[3] NCI, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15628
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Outcomes of children with hereditary medullary thyroid carcinoma (MTC) treated with vandetanib.
    Kraft, Ira Lignugaris
    Akshintala, Srivandana
    Derse-Anthony, Claudia
    Steinberg, Seth M.
    Venzon, David J.
    Dombi, Eva
    Waguespack, Steven G.
    Kapustina, Oxana Borisovna
    Fox, Elizabeth
    Balis, Frank M.
    Shern, John Frederick
    Glod, John
    Widemann, Brigitte C.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] TREATMENT WITH VANDETANIB IN A 11 YEARS OLD BOY WITH ADVANCED MEDULLARY THYROID CARCINOMA
    Papendieck, Patricia
    Vieites, Ana
    Elias, Eugenia
    Garcia Lombardi, Mercedes
    Chiesa, Ana
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 596 - 596
  • [23] Outcomes of Children and Adolescents with Advanced Hereditary Medullary Thyroid Carcinoma Treated with Vandetanib
    Kraft, Ira L.
    Akshintala, Srivandana
    Zhu, Yuelin
    Lei, Haiyan
    Derse-Anthony, Claudia
    Dombi, Eva
    Steinberg, Seth M.
    Lodish, Maya
    Waguespack, Steven G.
    Kapustina, Oxana
    Fox, Elizabeth
    Balis, Frank M.
    Merino, Maria J.
    Meltzer, Paul S.
    Glod, John W.
    Shern, Jack F.
    Widemann, Brigitte C.
    CLINICAL CANCER RESEARCH, 2018, 24 (04) : 753 - 765
  • [24] Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
    Degrauwe, Nils
    Sosa, Julie Ann
    Roman, Sanziana
    Deshpande, Hari A.
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2012, 6
  • [25] Role of vandetanib in the management of medullary thyroid cancer
    Brassard, Maryse
    Rondeau, Genevieve
    BIOLOGICS-TARGETS & THERAPY, 2012, 6 : 59 - 66
  • [26] Vandetanib and the management of advanced medullary thyroid cancer
    Campbell, Michael J.
    Seib, Carolyn D.
    Gosnell, Jessica
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 39 - 43
  • [27] Vandetanib in progressive and symptomatic medullary thyroid cancer
    Hartmann, Milan
    Faust, Michael
    Chiapponi, Costanza
    Alakus, Hakan
    Bruns, Christiane J.
    ONKOLOGE, 2020, 26 (12): : 1172 - 1174
  • [28] Molecular targets in medullary thyroid carcinoma
    Moore, Sam W.
    GENE THERAPY AND MOLECULAR BIOLOGY, 2008, 12B : 181 - 188
  • [29] Molecular Diagnosis of Medullary Thyroid Carcinoma
    Goel, Kanika
    Silverman, Jan F.
    Narick, Christina
    Finkelstein, Sydney
    LABORATORY INVESTIGATION, 2018, 98 : 231 - 231
  • [30] Molecular Diagnosis of Medullary Thyroid Carcinoma
    Goel, Kanika
    Silverman, Jan F.
    Narick, Christina
    Finkelstein, Sydney
    MODERN PATHOLOGY, 2018, 31 : 231 - 231
12345